Skip to main content
. 2023 Oct 5;17:17534666231199693. doi: 10.1177/17534666231199693

Figure 3.

Figure 3.

Sankey diagram demonstrating changes in ERS/ESC 2022 simplified four-strata risk category on addition of third sequential drug. Interestingly, no patient remained in high-risk category after addition of third sequential drug.

ERS/ESC, European Respiratory Society/European Society of Cardiology.